172 related articles for article (PubMed ID: 31754627)
1. Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer.
Haynes BP; Ginsburg O; Gao Q; Folkerd E; Afentakis M; Buus R; Quang LH; Thi Han P; Khoa PH; Dinh NV; To TV; Clemons M; Holcombe C; Osborne C; Evans A; Skene A; Sibbering M; Rogers C; Laws S; Noor L; Smith IE; Dowsett M
NPJ Breast Cancer; 2019; 5():42. PubMed ID: 31754627
[TBL] [Abstract][Full Text] [Related]
2. Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.
Haynes BP; Viale G; Galimberti V; Rotmensz N; Gibelli B; Smith IE; Dowsett M
Breast Cancer Res Treat; 2014 Nov; 148(2):327-35. PubMed ID: 25367875
[TBL] [Abstract][Full Text] [Related]
3. Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer.
Haynes BP; Viale G; Galimberti V; Rotmensz N; Gibelli B; A'Hern R; Smith IE; Dowsett M
Breast Cancer Res Treat; 2013 Feb; 138(1):157-65. PubMed ID: 23378065
[TBL] [Abstract][Full Text] [Related]
4. Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Haynes BP; Schuster G; Buus R; Alataki A; Ginsburg O; Quang LH; Han PT; Khoa PH; Van Dinh N; Van To T; Clemons M; Holcombe C; Osborne C; Evans A; Skene A; Sibbering M; Rogers C; Laws S; Noor L; Cheang MCU; Cleator SJ; Smith IE; Dowsett M
Breast Cancer Res Treat; 2021 Nov; 190(2):295-305. PubMed ID: 34524591
[TBL] [Abstract][Full Text] [Related]
5. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
[TBL] [Abstract][Full Text] [Related]
6. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
7. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
[TBL] [Abstract][Full Text] [Related]
8. Changes in mental health during three waves of the COVID-19 pandemic: a repeated cross-sectional study among polish university students.
Rogowska AM; Ochnik D; Kuśnierz C; Chilicka K; Jakubiak M; Paradowska M; Głazowska L; Bojarski D; Fijołek J; Podolak M; Tomasiewicz M; Nowicka D; Kawka M; Grabarczyk M; Babińska Z
BMC Psychiatry; 2021 Dec; 21(1):627. PubMed ID: 34911485
[TBL] [Abstract][Full Text] [Related]
9. Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy.
Haynes BP; Ginsburg O; Gao Q; Folkerd E; Afentakis M; Quang LH; Han PT; Khoa PH; Dinh NV; To TV; Clemons M; Smith IE; Dowsett M
NPJ Breast Cancer; 2017; 3():47. PubMed ID: 29214214
[TBL] [Abstract][Full Text] [Related]
10. [Effects of supplemental irrigation based on the measurement of moisture content in different soil layers on the water consumption characteristics and grain yield of winter wheat].
Yi LP; Yu ZW; Zhang YL; Wang D; Shi Y; Zhao JY
Ying Yong Sheng Tai Xue Bao; 2013 May; 24(5):1361-6. PubMed ID: 24015556
[TBL] [Abstract][Full Text] [Related]
11. [Effects of UV-B Radiation on Soil Carbon and Nitrogen Transformation under Different Soil Moisture Contents from Two Paddy Fields].
Jiang MD; Wang QM; Xu P; Zhou W; Wu L; Hu RG
Huan Jing Ke Xue; 2017 Nov; 38(11):4819-4827. PubMed ID: 29965428
[TBL] [Abstract][Full Text] [Related]
12. Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005-2017): the International Diabetes Management Practices Study (IDMPS).
Mbanya JC; Aschner P; Gagliardino JJ; İlkova H; Lavalle F; Ramachandran A; Chantelot JM; Chan JCN
Diabetologia; 2021 Jun; 64(6):1246-1255. PubMed ID: 33594476
[TBL] [Abstract][Full Text] [Related]
13. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast.
Battersby S; Robertson BJ; Anderson TJ; King RJ; McPherson K
Br J Cancer; 1992 Apr; 65(4):601-7. PubMed ID: 1562470
[TBL] [Abstract][Full Text] [Related]
14. Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study.
Giacomelli A; Ridolfo AL; Pezzati L; Oreni L; Carrozzo G; Beltrami M; Poloni A; Caloni B; Lazzarin S; Colombo M; Pozza G; Pagano S; Caronni S; Fusetti C; Gerbi M; Petri F; Borgonovo F; D'Aloia F; Negri C; Rizzardini G; Antinori S
PLoS One; 2022; 17(4):e0263548. PubMed ID: 35404963
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
16. Estradiol, progesterone and steroid receptors. Benign cycling versus malignant non cycling cells.
Ferrer-Roca O; Ribera F; Sanchez L; Estevez M
Adv Clin Path; 1997 Jan; 1(1):75-84. PubMed ID: 10352470
[TBL] [Abstract][Full Text] [Related]
17. Comparison of hormone-induced mRNA and protein biomarker expression changes in breast cancer cells.
Bernhardt SM; Dasari P; Glynn DJ; Townsend AR; Price TJ; Ingman WV
Breast Cancer Res Treat; 2021 Jun; 187(3):681-693. PubMed ID: 34057651
[TBL] [Abstract][Full Text] [Related]
18. Effects of fulvestrant 750mg in premenopausal women with oestrogen-receptor-positive primary breast cancer.
Young OE; Renshaw L; Macaskill EJ; White S; Faratian D; Thomas JS; Dixon JM
Eur J Cancer; 2008 Feb; 44(3):391-9. PubMed ID: 18083023
[TBL] [Abstract][Full Text] [Related]
19. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle.
Weimer DA; Donegan WL
Breast Cancer Res Treat; 1987 Dec; 10(3):273-8. PubMed ID: 3447646
[TBL] [Abstract][Full Text] [Related]
20. High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.
Kunc M; Pęksa R; Cserni G; Iżycka-Świeszewska E; Łacko A; Radecka B; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Szwajkosz A; Biernat W; Senkus E
Pathology; 2022 Apr; 54(3):269-278. PubMed ID: 35074178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
